UPDATE: Incyte and Lexicon Genetics Set their Sights on Secreted Proteins | GenomeWeb

NEW YORK, June 28 - Hoping to combine genomic and proteomic data with drug target validation technology, Incyte and Lexicon Genetics have agreed to an anticipated five-year drug discovery partnership focusing on proteins secreted through cell membranes.

A panel of scientists from Incyte and Lexicon plan to jointly identify 250 secreted proteins with potential as therapeutic agents, and run them through Lexicon's mouse-based gene knockout system to determine their utility. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.